SNHG5 and neoplasm: Furthermore, the results from controlled clinical trials also revealed that higher expression of SNHG5 is significantly positively correlated with a smaller size of the tumor (Figure 1(b)), earlier TNM stage (Figure 1(c)), and clinical-pathological negative lymph node metastasis (Figure 1(d)) of LAD.